enkephalin, Met(2)-ProNH2(5)-
基本情報
- CAS
63307-63-1- 標準SMILES
CSCC[C@@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(N)=O- InChIKey
UIRWGVLTPPSGEN-NDBXHCKUSA-N- 分子式
- C30H40N6O6S
- 平均分子量
- 612.7 g/mol
- 単同位体質量
- 612.27300419
名称と識別子
- 優先名称
- enkephalin, Met(2)-ProNH2(5)-
- IUPAC
- (2S)-1-[(2S)-2-[[2-[[(2R)-2-[[(2S)-2-amino-3-(4-hydroxyphenyl)propanoyl]amino]-4-methylsulfanylbutanoyl]amino]acetyl]amino]-3-phenylpropanoyl]pyrrolidine-2-carboxamide
- 英語名
- [D- Met2 , Pro5 ]-enkephalinamide
- 分子式
- C30H40N6O6S
- 分子量
- 612.7402
名称と別名
63307-63-1L-Tyrosyl-D-methionylglycyl-L-phenylalanyl-L-prolinamide2-Met-5-ProNH2-enkephalinD-Met(2)-Pro(5)-enkephalinamideenkephalin, Met(2)-ProNH2(5)-enkephalin, methionyl(2)-prolinamide(5)-RefChem:136872(D-Met2,Pro5)-EnkephalinamideCHEMBL4095111(2S)-1-[(2S)-2-[[2-[[(2R)-2-[[(2S)-2-amino-3-(4-hydroxyphenyl)propanoyl]amino]-4-methylsulfanylbutanoyl]amino]acetyl]amino]-3-phenylpropanoyl]pyrrolidine-2-carboxamide[D- MET2 , PRO5 ]-ENKEPHALINAMIDETyr-D-Met-Gly-Phe-Pro-NH2
名称をさらに表示
gyki14238met(2)-pronh2(5)-enkephalid-met(sup2)pro(sup5)-enkephalinamidel-tyrosyl-d-methionylglycyl-l-phenylalanyl-l-prolinamidL-Prolinamide, L-tyrosyl-D-methionylglycyl-L-phenylalanyl- (9CI)
GYKI 14238D-Met(sup 2)pro(sup 5)-enkephalinamideorb1745096SCHEMBL11065220DTXSID80979407L-Prolinamide, L-tyrosyl-D-methionylglycyl-L-phenylalanyl-HY-P3547BDBM50233414
データベース識別子
- CAS
63307-63-1- PubChem CID
- 123894
- DTXSID
DTXSID80979407- ChEMBL
CHEMBL4095111- Nikkaji
- J265.189K
物性
構造計算による物性
- XLogP
- 1
- 極性表面積
- 222 Ų
- 水素結合供与体数
- 6
- 水素結合受容体数
- 8
- 回転可能結合数
- 15
- 重原子数
- 43
- 形式電荷
- 0
- 複雑度
- 955
化学と産業
薬理情報
MeSH Pharmacological Classification
Compounds capable of relieving pain without the loss of CONSCIOUSNESS.
Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade.
関連反応
0 件
現在のフィルター条件では反応記録がありません。
化合物ノート
読み込み中…